During the past trading week (January 20 to 31), the cannabis industry saw a pair of executive changes as the industry continues to see CEO shake-ups.

The marijuana space also saw its latest high-profile lawsuit as it was revealed HEXO (NYSE:HEXO,TSX:HEXO) is the company at the center of the missing payment claim made by MediPharm Labs (TSX:LABS,OTCQX:MEDIF).

Here’s a closer look at some of the biggest cannabis news over the week.

CEO changes in the cannabis space

Sundial Growers (NASDAQ:SNDL) and MedMen Enterprises (CSE:MMEN,OTCQX:MMNFF) are the latest cannabis companies to see a change in the CEO position.

Shares of MedMen jumped on Friday’s trading session by 9.26 percent as of 1:11 p.m. EST to a price of C$0.59 following the announced departure of Adam Bierman as CEO.

“I continue to believe that MedMen is positioned to thrive. It’s time for our next iteration of leadership to capitalize on the opportunity we have created,” Bierman said in a statement.

The multi-state operator confirmed Bierman, a co-founder of the company, would give all of the class A super voting shares under his name back to the firm. MedMen announced that Chief Operating Officer and Chief Technology Officer Ryan Lissack will take over as interim CEO.

As a part of this executive shake-up, MedMen co-founder Andrew Modlin will also submit his Class A super voting shares. Due to these share changes, the company said by the end of 2020 it will only count with class B subordinate voting shares, each representing one vote.

On the other hand, Sundial saw both Torsten Kuenzlen and Brian Harriman, CEO and chief operating officer respectively, leave the company. The company indicated that Kuenzlen’s decision to leave was to “pursue other interests.”

The executive changes caused the company to face a severe drop off in valuation. Shares of Sundial dropped nearly 40 percent during last Thursday’s (January 30) trading session.

The losses continued on Friday (January 31) for Sundial as it saw an additional double-digit drop in value.

So far in January, TerrAscend (CSE:TER,OTCQX:TRSSF) and The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) have also faced executive changes.

chart for shares of Sundial

New lawsuit traced back to LP acquisition deal

After MediPharm told investors about a claim filed against an undisclosed licensed producer (LP), the identity of the company it’s chasing was revealed.

HEXO is facing the fallout of this deal gone wrong since it was a transaction done between MediPharm and UP Cannabis, a division of Newstrike Brands. HEXO completed its acquisition of Newstrike in March 2019.

MediPharm claims wrongdoing from a missing C$9.8 million payment as part of an agreed upon transaction with UP Cannabis for cannabis oil items.

“The contract is a supply agreement for which we had serious concerns and, in an effort to drive value for our shareholders, we attempted to work in good faith towards a resolution that was suitable for both parties. Unfortunately, these efforts were unsuccessful,” a HEXO spokesperson told BNN Bloomberg.

Market updates

An audio recording from a donor’s dinner in 2018 showed an inside conversation of US President Donald Trump discussing cannabis policy in the US and its benefits.

This tape was part of the larger releases done by an attorney of Lev Parnas, a Soviet-born businessman who worked alongside Trump’s associate and lawyer Rudy Giuliani and is now at the center of the impeachment inquiries held against Trump.

This past week, Ontario Premier Doug Ford made a fiery television appearance to defending the roll-out of his province’s marijuana retail plan.

“We’re doing it responsibly,” Ford said to BNN Bloomberg. “We’re going to roll out the market and keep in mind it’s only been a little over a year and a bit and we’re opening up to the market.”

The slow Ontario roll-out of cannabis shops has become the de-facto punching bag for Canadian cannabis producers when it comes to the poor performance of the sector. The province has decided to take away a lottery system to open up the entire retail model based on standardized license applications.

“We’re going to have more stores than all the provinces combined, so we’re going to make everything we can to help the cannabis industry,” Ford said.

Florida-based cannabis operator Liberty Health Sciences (CSE:LHS,OTCQX:LHSIF) issued its latest quarterly results report to investors. The firm credited the development of the Florida market as the main driver of its growth year-over-year.

Liberty Health Sciences reported a net income of US$6.9 million thanks to a net sales mark of US$16.1 million for the period ended on November 30, 2019. The company manages 23 dispensaries in the state of Florida, which has proven to be one of the more intriguing cannabis markets in the US.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less